Who
Michael A. Friedman
Director
Company insider
Files Form 4 as: Director, MannKind; Director, Celgene Corp /de/; Director, Intuitive Surgical.
In numbers
- Trades disclosed
- 152
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $13.5M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 25 May 2006
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,781 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,781 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —52,854 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —35,047 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —35,545 at $0.00 | filing |
| 10 May 2022filed 12 May 2022 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —45,045 at $0.00 | filing |
| 20 May 2021filed 20 May 2021 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —33,860 at $0.00 | filing |
| 21 May 2020filed 26 May 2020 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —88,235 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —3,600 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —20,700 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —10,000 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —11,000 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —10,500 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —13,266 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —300 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —970 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code D | —4,756 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | Celgene Corp /de/ | SEC FORM 4 Code D | —19,847 at $0.00 | filing |
| 15 Jun 2019filed 17 Jun 2019 | Celgene Corp /de/option or derivative | SEC FORM 4 Code M | —375 at $0.00 | filing |
| 15 Jun 2019filed 17 Jun 2019 | Celgene Corp /de/ | SEC FORM 4 Code M | —375 at $0.00 | filing |
News
Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysISRG · dailypolitical.com · 21 Oct 2026Here Are Wednesday's Top Wall Street Analyst Research Calls: Applied Digital, Chipotle Mexican Grill, Cirrus Logic, Costco, Digital Realty Trust, Intuitive Surgical, Netflix, Robinhood Markets, Zscaler, and MoreISRG · aol.com · 21 Oct 2026Intuitive Surgical Q3 2026: $3.00 EPS Beats Estimates, 546 Robot PlacementsISRG · 247wallst.com · 20 Oct 2026
0 headlines in the last 90 days name Michael A. Friedman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.